Regenxbio Net Debt from 2010 to 2024

RGNX Stock

USD 10.01 0.46 4.82%

Regenxbio Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt is likely to outpace its year average in 2024. Net Debt is the total debt of Regenxbio minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2014-03-31

Previous Quarter

101 M

Current Value

27.4 M

Quarterly Volatility

80.9 M

Yuan Drop

Covid

Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.2 M, Interest Expense of 6.5 M or Selling General Administrative of 47.8 M, as well as many indicators such as Price To Sales Ratio of 8.26, Dividend Yield of 0.0 or PTB Ratio of 2.64. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.

Check out the analysis of Regenxbio Correlation against competitors.

For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Net Debt Growth Pattern

Below is the plot of the Net Debt of Regenxbio over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Regenxbio's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Net Debt

Timeline

Regenxbio Net Debt Regression Statistics

	Arithmetic Mean	(44,552,773)
	Geometric Mean	11,390,237
	Coefficient Of Variation	(214.60)
	Mean Deviation	64,757,648
	Median	(2,153,000)
	Standard Deviation	95,611,676
	Sample Variance	9141.6T
	Range	323.3M
	R-Value	(0.19)
	Mean Square Error	9476.6T
	R-Squared	0.04
	Significance	0.49
	Slope	(4,134,836)
	Total Sum of Squares	127982.3T

Regenxbio Net Debt History

	2024	57.5 M
	2023	54.8 M
	2022	-2.2 M
	2021	-258.5 M
	2020	-265.8 M
	2019	-58.2 M
	2018	-69.7 M

Other Fundumenentals of Regenxbio

Net Debt To E B I T D A

Regenxbio Net Debt component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Short Term Investments	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Property Plant Equipment	Capital Surpluse	Net Invested Capital	Net Working Capital	Long Term Debt Total	Capital Stock
Total Assets		0.96	0.75	-0.58	-0.54	0.71	0.84	0.89	0.96	0.53	-0.63	0.95	0.68	0.69	0.83	-0.17	0.73	0.89	0.92	0.85	-0.17	-0.17
Total Stockholder Equity	0.96		0.82	-0.55	-0.43	0.6	0.76	0.73	0.93	0.42	-0.67	0.96	0.69	0.7	0.87	-0.13	0.64	0.81	0.94	0.82	-0.13	-0.13
Current Deferred Revenue	0.75	0.82		-0.5	-0.17	0.34	0.69	0.5	0.7	0.14	-0.59	0.74	0.5	0.6	0.79	0.13	0.38	0.6	0.76	0.59	0.13	0.13
Net Debt	-0.58	-0.55	-0.5		-0.2	0.07	-0.53	-0.51	-0.61	0.26	0.29	-0.42	0.02	-0.3	-0.59	-0.4	0.02	-0.27	-0.49	-0.68	-0.4	-0.4
Retained Earnings	-0.54	-0.43	-0.17	-0.2		-0.93	-0.55	-0.63	-0.56	-0.97	0.48	-0.6	-0.66	-0.56	-0.09	0.8	-0.89	-0.73	-0.4	-0.41	0.8	0.8
Accounts Payable	0.71	0.6	0.34	0.07	-0.93		0.64	0.77	0.68	0.95	-0.49	0.7	0.74	0.56	0.34	-0.64	0.94	0.84	0.6	0.53	-0.64	-0.64
Net Receivables	0.84	0.76	0.69	-0.53	-0.55	0.64		0.83	0.9	0.49	-0.5	0.78	0.65	0.59	0.51	-0.18	0.6	0.81	0.73	0.86	-0.18	-0.18
Total Liab	0.89	0.73	0.5	-0.51	-0.63	0.77	0.83		0.86	0.62	-0.44	0.77	0.53	0.55	0.61	-0.21	0.77	0.88	0.72	0.75	-0.21	-0.21
Total Current Assets	0.96	0.93	0.7	-0.61	-0.56	0.68	0.9	0.86		0.52	-0.67	0.92	0.72	0.74	0.69	-0.18	0.66	0.86	0.85	0.91	-0.18	-0.18
Short Term Debt	0.53	0.42	0.14	0.26	-0.97	0.95	0.49	0.62	0.52		-0.48	0.57	0.65	0.46	0.14	-0.79	0.91	0.71	0.42	0.37	-0.79	-0.79
Common Stock	-0.63	-0.67	-0.59	0.29	0.48	-0.49	-0.5	-0.44	-0.67	-0.48		-0.69	-0.54	-0.69	-0.45	0.22	-0.44	-0.53	-0.49	-0.49	0.22	0.22
Net Tangible Assets	0.95	0.96	0.74	-0.42	-0.6	0.7	0.78	0.77	0.92	0.57	-0.69		0.76	0.74	0.78	-0.27	0.75	0.91	0.88	0.75	-0.27	-0.27
Short Term Investments	0.68	0.69	0.5	0.02	-0.66	0.74	0.65	0.53	0.72	0.65	-0.54	0.76		0.68	0.36	-0.3	0.63	0.8	0.62	0.55	-0.3	-0.3
Deferred Long Term Liab	0.69	0.7	0.6	-0.3	-0.56	0.56	0.59	0.55	0.74	0.46	-0.69	0.74	0.68		0.43	-0.18	0.51	0.68	0.55	0.55	-0.18	-0.18
Long Term Investments	0.83	0.87	0.79	-0.59	-0.09	0.34	0.51	0.61	0.69	0.14	-0.45	0.78	0.36	0.43		0.14	0.46	0.61	0.85	0.58	0.14	0.14
Short Long Term Debt	-0.17	-0.13	0.13	-0.4	0.8	-0.64	-0.18	-0.21	-0.18	-0.79	0.22	-0.27	-0.3	-0.18	0.14		-0.69	-0.32	-0.22	-0.2	1.0	1.0
Property Plant Equipment	0.73	0.64	0.38	0.02	-0.89	0.94	0.6	0.77	0.66	0.91	-0.44	0.75	0.63	0.51	0.46	-0.69		0.85	0.68	0.52	-0.69	-0.69
Capital Surpluse	0.89	0.81	0.6	-0.27	-0.73	0.84	0.81	0.88	0.86	0.71	-0.53	0.91	0.8	0.68	0.61	-0.32	0.85		0.77	0.67	-0.32	-0.32
Net Invested Capital	0.92	0.94	0.76	-0.49	-0.4	0.6	0.73	0.72	0.85	0.42	-0.49	0.88	0.62	0.55	0.85	-0.22	0.68	0.77		0.84	-0.22	-0.22
Net Working Capital	0.85	0.82	0.59	-0.68	-0.41	0.53	0.86	0.75	0.91	0.37	-0.49	0.75	0.55	0.55	0.58	-0.2	0.52	0.67	0.84		-0.2	-0.2
Long Term Debt Total	-0.17	-0.13	0.13	-0.4	0.8	-0.64	-0.18	-0.21	-0.18	-0.79	0.22	-0.27	-0.3	-0.18	0.14	1.0	-0.69	-0.32	-0.22	-0.2		1.0
Capital Stock	-0.17	-0.13	0.13	-0.4	0.8	-0.64	-0.18	-0.21	-0.18	-0.79	0.22	-0.27	-0.3	-0.18	0.14	1.0	-0.69	-0.32	-0.22	-0.2	1.0

Click cells to compare fundamentals

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	54.8 M	57.5 M
Net Debt To EBITDA	(0.23)	(0.22)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Regenxbio Net Debt from 2010 to 2024

Latest Regenxbio's Net Debt Growth Pattern

Regenxbio Net Debt Regression Statistics

Regenxbio Net Debt History

Other Fundumenentals of Regenxbio

Regenxbio Net Debt component correlations

About Regenxbio Financial Statements

Also Currently Popular

Additional Tools for Regenxbio Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY